SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy
- First Posted Date
- 2003-08-29
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 36
- Registration Number
- NCT00006002
- Locations
- ๐บ๐ธ
Cancer Center and Beckman Research Institute, City of Hope, Duarte, California, United States
๐บ๐ธIngalls Memorial Hospital, Harvey, Illinois, United States
๐บ๐ธUSC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
- First Posted Date
- 2003-08-05
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 24
- Registration Number
- NCT00022477
- Locations
- ๐บ๐ธ
University of Illinois at Chicago, Chicago, Illinois, United States
๐บ๐ธLouis A. Weiss Memorial Hospital, Chicago, Illinois, United States
๐บ๐ธUniversity of Chicago Cancer Research Center, Chicago, Illinois, United States
PS-341 in Treating Patients With Metastatic Kidney Cancer
- First Posted Date
- 2003-06-17
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 23
- Registration Number
- NCT00025376
- Locations
- ๐บ๐ธ
Louis A. Weiss Memorial Hospital, Chicago, Illinois, United States
๐บ๐ธLoyola University Medical Center, Maywood, Illinois, United States
๐บ๐ธCancer Care Specialists of Central Illinois, S.C., Decatur, Illinois, United States
Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-05-16
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 6
- Registration Number
- NCT00005086
- Locations
- ๐บ๐ธ
Louis A. Weiss Memorial Hospital, Chicago, Illinois, United States
๐บ๐ธFort Wayne Medical Oncology and Hematology, Inc., Fort Wayne, Indiana, United States
๐บ๐ธUniversity of Chicago Cancer Research Center, Chicago, Illinois, United States
Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach
- Conditions
- Interventions
- First Posted Date
- 2003-05-07
- Last Posted Date
- 2013-02-11
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 35
- Registration Number
- NCT00004127
- Locations
- ๐บ๐ธ
University of Illinois at Chicago, Chicago, Illinois, United States
๐บ๐ธLouis A. Weiss Memorial Hospital, Chicago, Illinois, United States
๐บ๐ธLutheran General Cancer Care Center, Park Ridge, Illinois, United States
Drug Treatment for Pathologic Gambling Disorder
- First Posted Date
- 2003-02-05
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 83
- Registration Number
- NCT00053677
- Locations
- ๐บ๐ธ
University of Minnesota Medical School, Minneapolis, Minnesota, United States
Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine
- First Posted Date
- 2003-01-28
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 13
- Registration Number
- NCT00053222
- Locations
- ๐บ๐ธ
Oncology/Hematology Associates of Central Illinois, P.C., Peoria, Illinois, United States
๐บ๐ธLaGrange Memorial Hospital, LaGrange, Illinois, United States
๐บ๐ธIngalls Memorial Hospital, Harvey, Illinois, United States
Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-02-11
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 8
- Registration Number
- NCT00025389
- Locations
- ๐บ๐ธ
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus, Ohio, United States
๐บ๐ธUniversity of Chicago Cancer Research Center, Chicago, Illinois, United States
Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2014-03-07
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 13
- Registration Number
- NCT00015977
- Locations
- ๐บ๐ธ
University of Chicago Cancer Research Center, Chicago, Illinois, United States
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 46
- Registration Number
- NCT00004141
- Locations
- ๐บ๐ธ
University of Chicago Cancer Research Center, Chicago, Illinois, United States